YOLFTbeta
00

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

000999 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

25.45CNY+0.41 (+1.64%)

Price History

Full chart

Market Stats

Previous Close25.04
Open25.07
Day Range24.73 – 25.60
52-Week Range21.60 – 29.90
Volume10.33M
Market Cap40.26B
P/E (TTM)12.28
Forward P/E16.47
EPS1.97
Dividend Yield5.49%
Beta-0.02
50-Day Avg24.61
200-Day Avg26.39

About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wen Duo Wu
  • Employees30.30K
  • HeadquartersGuanlan High-tech Park, Shenzhen, China, 518110, China
  • Websitehttps://www.999.com.cn

Leadership

  • Mr. Wen Duo WuPresident & Director · b. 1974
  • Mr. Jian XingCFO & Secretary of the Board · b. 1978
  • Mr. Yi MaiVice President · b. 1967
  • Mr. Liang WangVice President · b. 1979
  • Mr. Ke WangVice President · b. 1974
  • Mr. Yu XiangVice President · b. 1981

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.11B1.43B1.48B1.63B1.87B2.17B2.67B2.46B2.97B2.87B3.40B4.32B4.85B4.37B5.45B6.94B7.29B7.28B7.90B8.98B11.12B13.43B14.79B13.64B15.54B18.08B24.74B27.62B31.60B
Growth (%)-+28.48%+3.54%+10.26%+14.71%+15.98%+23.49%-7.96%+20.63%-3.42%+18.48%+27.03%+12.43%-10.05%+24.95%+27.30%+5.04%-0.23%+8.57%+13.69%+23.81%+20.75%+10.17%-7.82%+13.98%+16.31%+36.83%+11.63%+14.43%
Cost of Revenue487.21M604.72M627.09M820.84M917.00M1.10B1.35B1.36B1.56B1.57B1.78B2.38B2.40B1.69B2.27B2.71B2.71B2.83B3.09B3.38B3.90B4.17B4.90B5.14B6.56B8.35B11.67B13.43B14.57B
Gross Profit622.62M821.16M849.33M806.99M950.32M1.06B1.32B1.10B1.41B1.36B1.62B1.97B2.46B2.68B3.26B4.24B4.59B4.44B4.81B5.60B7.22B9.26B9.89B8.49B8.98B9.73B13.06B14.18B17.04B
Gross Margin56.10%57.59%57.53%49.57%50.89%49.05%49.38%44.61%47.49%47.41%47.59%45.70%50.62%61.37%59.73%61.03%62.91%61.05%60.90%62.39%64.92%68.96%66.85%62.28%57.79%53.79%52.81%51.36%53.91%
Operating Expense524.11M677.91M641.07M641.59M823.60M876.69M1.04B1.75B1.04B1.11B1.10B1.34B1.57B1.72B2.35B2.97B3.25B3.21B3.37B4.32B5.71B7.56B7.37B6.42B6.51B6.78B9.31B9.71B12.18B
Operating Income98.52M143.24M208.26M165.40M126.72M185.68M279.79M-649.82M372.63M253.93M520.23M634.99M884.97M962.63M909.04M1.26B1.34B1.23B1.44B1.28B1.51B1.70B2.51B2.07B2.47B2.95B3.75B4.48B4.85B
Operating Margin8.88%10.05%14.11%10.16%6.79%8.57%10.46%-26.40%12.55%8.85%15.31%14.71%18.24%22.05%16.67%18.19%18.41%16.88%18.26%14.28%13.58%12.69%17.00%15.18%15.90%16.30%15.17%16.20%15.35%
EBITDA147.74M171.66M300.58M353.90M380.56M425.03M526.86M-385.53M451.89M506.91M600.15M744.92M1.02B1.15B1.09B1.52B1.60B1.52B1.79B1.77B1.87B2.10B2.90B2.46B2.89B3.45B4.53B5.32B5.50B
EBITDA Margin13.31%12.04%20.36%21.74%20.38%19.63%19.70%-15.66%15.22%17.68%17.66%17.26%21.02%26.43%20.04%21.95%21.92%20.95%22.69%19.67%16.80%15.60%19.58%18.01%18.59%19.10%18.29%19.25%17.40%
Net Income98.80M150.83M220.22M161.33M121.03M165.02M208.80M-720.80M117.75M164.92M279.80M500.09M709.49M815.98M760.45M1.02B1.11B1.04B1.25B1.20B1.30B1.43B2.10B1.60B2.06B2.45B2.85B3.37B3.42B
Net Income Margin8.90%10.58%14.92%9.91%6.48%7.62%7.81%-29.28%3.97%5.75%8.23%11.59%14.62%18.69%13.94%14.71%15.20%14.24%15.81%13.34%11.71%10.67%14.19%11.71%13.22%13.54%11.53%12.20%10.83%
R&D-------------71.55M102.95M159.67M198.37M231.80M236.46M286.79M297.34M355.84M455.75M459.84M30.62M612.28M767.60M801.75M1.34B
R&D as % of Total Revenue-------------1.64%1.89%2.30%2.72%3.19%2.99%3.19%2.67%2.65%3.08%3.37%0.20%3.39%3.10%2.90%4.24%
Interest Expense21.60M29.40M25.09M102.79M157.60M172.25M189.77M203.53M204.68M198.76M120.79M14.36M9.60M1.81M10.50M8.80M24.88M29.19M28.94M29.29M29.43M27.88M6.36M6.89M16.53M22.74M85.17M84.07M122.57M
Interest Expense % of Total Revenue1.95%2.06%1.70%6.31%8.44%7.95%7.10%8.27%6.89%6.93%3.55%0.33%0.20%0.04%0.19%0.13%0.34%0.40%0.37%0.33%0.26%0.21%0.04%0.05%0.11%0.13%0.34%0.30%0.39%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.47B1.71B3.58B5.68B6.60B6.85B8.30B7.18B7.04B7.13B7.94B5.11B5.63B6.59B7.60B8.67B9.98B10.67B12.02B13.55B16.20B18.03B21.40B22.15B24.54B27.12B40.15B40.08B58.80B
Total Liabilities897.21M959.69M925.96M2.81B3.65B3.88B5.25B4.89B4.65B4.52B4.98B1.70B1.68B1.86B2.75B3.07B3.78B3.67B4.35B4.83B6.07B6.86B8.32B8.10B8.77B9.59B15.89B14.83B20.03B
Total Equity519.17M694.79M2.58B2.52B2.60B2.77B2.86B2.11B2.23B2.45B2.78B3.20B3.69B4.48B4.54B5.34B5.98B6.76B7.57B8.62B9.84B10.83B12.76B13.72B15.31B17.01B18.97B19.90B22.17B
Cash252.58M76.57M1.17B2.29B1.31B1.77B2.25B643.63M363.86M548.89M846.63M718.32M1.27B1.78B2.02B1.35B1.18B1.14B973.17M910.82M1.71B2.48B3.09B3.82B3.07B3.15B6.77B5.02B4.66B
Total Debt365.94M331.52M240.87M1.91B2.87B2.67B4.11B3.41B3.25B3.23B3.13B110.08M51.54M85.41M65.52M105.35M523.81M540.20M499.68M519.74M30.23M45.16M40.21M173.20M186.71M324.54M2.81B1.13B6.42B
Net Debt113.36M254.95M-927.59M-376.12M1.55B905.86M1.86B2.77B2.88B2.68B2.28B-608.24M-1.22B-1.70B-1.96B-1.25B-658.80M-599.81M-473.49M-391.08M-1.68B-2.43B-3.05B-3.65B-2.88B-2.83B-3.96B-3.89B1.76B

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow120.63M266.86M153.44M496.12M28.09M-719.63M22.83M425.51M605.30M1.12B855.05M848.28M954.90M1.21B1.47B1.18B1.26B1.39B1.60B1.91B1.97B2.22B1.88B3.01B4.19B4.40B5.51B
Investing Cash Flow-883.14M-1.58B-1.23B-379.00M-1.08B-71.16M1.35M-125.23M-226.70M-1.26B-93.05M-67.82M-385.00M-1.54B-1.55B-919.61M-789.82M-1.22B-590.43M-890.73M-511.37M-659.34M-1.79B-2.48B-793.50M-1.13B-7.41B
Financing Cash Flow1.51B1.20B649.51M-216.31M1.15B-222.46M61.98M-121.81M-154.26M21.30M-213.34M-256.75M-345.38M-321.95M107.35M-313.94M-642.52M-224.22M-208.60M-432.64M-892.16M-1.47B-669.02M-575.45M450.42M-4.63B1.56B
Capital Expenditure73.43M170.58M118.83M172.67M135.88M84.59M37.14M135.81M226.78M1.20B192.93M270.00M409.79M504.52M354.89M341.22M330.65M354.33M374.74M600.36M535.97M621.82M870.80M951.57M857.21M790.07M1.27B
Free Cash Flow47.20M96.28M34.61M323.45M-107.78M-804.22M-14.32M289.69M378.52M-86.81M662.13M578.27M545.11M707.31M1.11B843.21M929.19M1.04B1.19B1.31B1.44B1.60B1.01B2.05B3.33B3.61B4.34B
Dividends Paid37.19M99.30M211.01M223.40M266.19M201.04M131.95M110.94M14.61M11.65M201.80M295.54M304.57M256.26M276.61M290.03M422.97M170.03M181.64M491.26M381.77M420.93M496.14M841.85M1.06B2.83B1.26B
FCF to OCF39.12%36.08%22.56%65.20%-383.65%111.75%-62.73%68.08%62.53%-7.78%77.44%68.17%57.09%58.37%75.82%71.19%73.75%74.55%74.16%68.59%72.82%72.04%53.70%68.35%79.55%82.05%78.67%
Dividend Paid to FCF78.81%103.14%609.70%69.07%-246.96%-25.00%-921.61%38.30%3.86%-13.42%30.48%51.11%55.87%36.23%24.86%34.40%45.52%16.38%15.32%37.48%26.59%26.27%49.02%40.97%31.67%78.47%28.95%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Mar 31, 2009Aug 5, 2009Oct 28, 2009Mar 1, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Apr 25, 2011Aug 5, 2011Oct 27, 2011Mar 6, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 25, 2013Aug 28, 2013Oct 28, 2013Feb 26, 2014Apr 25, 2014Aug 22, 2014Oct 28, 2014Mar 18, 2015Apr 29, 2015Aug 26, 2015Oct 28, 2015Mar 9, 2016Apr 25, 2016Aug 12, 2016Oct 30, 2016Mar 8, 2017Apr 27, 2017Aug 18, 2017Oct 29, 2017Mar 14, 2018Apr 28, 2018Aug 22, 2018Oct 29, 2018Mar 13, 2019Apr 26, 2019Aug 22, 2019Oct 29, 2019Mar 19, 2020Apr 29, 2020Aug 25, 2020Oct 29, 2020Mar 18, 2021Apr 29, 2021Aug 23, 2021Oct 26, 2021Mar 11, 2022Apr 22, 2022Aug 23, 2022Oct 28, 2022Mar 28, 2023Apr 28, 2023Aug 29, 2023Oct 27, 2023Mar 22, 2024Apr 19, 2024Aug 23, 2024Oct 25, 2024Mar 13, 2025Apr 28, 2025Aug 15, 2025Oct 24, 2025Mar 20, 2026Apr 24, 2026Jul 14, 2026
EPS Estimate--------0.080.100.09----0.190.100.140.14----0.24-0.18-0.250.200.37-----0.18-0.190.240.360.220.180.220.360.220.280.190.760.400.210.170.400.300.320.120.490.310.560.280.360.390.560.270.780.750.430.460.620.600.460.320.630.680.401.130.630.39
EPS Actual0.010.040.040.080.050.080.100.100.090.100.130.150.090.120.140.130.100.100.110.190.130.140.170.210.160.160.180.200.170.180.250.350.290.210.430.190.330.140.160.380.220.120.210.430.240.290.191.190.570.150.090.550.320.510.020.660.430.380.310.510.360.530.291.170.750.310.460.820.620.350.310.760.100.330.640.650.35
Surprise--------12.50%0.00%44.44%-----31.58%0.00%-28.57%-21.43%-----12.50%--11.11%--20.00%-15.00%-51.35%-----5.56%--26.32%-33.33%5.56%0.00%-33.33%-4.55%19.44%9.09%3.57%0.00%56.58%42.50%-28.57%-47.06%37.50%6.67%59.38%-83.33%34.69%38.71%-32.14%10.71%41.67%-7.69%-5.36%7.41%50.00%0.00%-27.91%0.00%32.26%3.33%-23.91%-3.13%20.63%-85.29%-17.50%-43.36%3.17%-10.26%
Timing--------Pre-marketPre-marketPre-market----After-hoursAfter-hoursAfter-hoursAfter-hours----After-hours-After-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap40.26B
Enterprise Value36.81B
Trailing P/E12.28
Forward P/E16.47
PEG Ratio1.38
Price / Sales1.27
Price / Book1.73
EPS1.97
Book Value13.72
Revenue (TTM)31.81B
Gross Profit (TTM)17.56B
EBITDA5.32B
Profit Margin10.30%
Operating Margin13.10%
Return on Equity10.30%
Return on Assets4.68%
Shares Outstanding1.66B
Shares Float562.72M
Beta-0.02
Dividend Yield5.49%
Dividend Rate1.29
Payout Ratio52.79%

Dividends

20262×
0.41Oct 16, 20260.59May 29, 2026
20252×
0.45Oct 17, 20250.25Jun 6, 2025
20242×
0.77Nov 29, 20241.15Jun 14, 2024
20231×
0.59Jun 15, 2023
20221×
0.50Aug 12, 2022
20211×
0.30Jul 9, 2021
20201×
0.25Jul 16, 2020
20191×
0.23Aug 8, 2019
20181×
0.27Jun 21, 2018
20171×
0.09Jul 14, 2017
20161×
0.09Jul 15, 2016
20151×
0.24Jul 10, 2015
20141×
0.15Jul 11, 2014
20131×
0.15Jul 26, 2013
20121×
0.14Aug 8, 2012
20111×
0.18Jun 9, 2011
20101×
0.18Apr 21, 2010
20091×
0.12Apr 23, 2009
20041×
0.03Jul 9, 2004
20031×
0.04Jun 11, 2003
20021×
0.02Jun 6, 2002

Stock Splits

  • Jun 6, 20251.3:1
  • Jun 14, 20241.3:1
  • Jun 11, 20031.3:1